News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Fuller & Thaler Asset Management, Inc. has filed an amended Schedule 13G, disclosing a 5.19% beneficial ownership stake in ICU Medical (ICUI). The firm holds 1,298,126.96 shares, with sole voting power over 1,276,819.96 shares and sole dispositive power over all 1,298,126.96 shares. The filing, …
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc (ICUI), sold 5,417 shares of the company on August 13, 2026, bringing his total ownership to 17,062 shares. This transaction is part of a trend where insiders at ICU Medical have generally been selling more …
Daniel Woolson, VP at ICU Medical (NASDAQ: ICUI), recently sold 5,417 shares of the company's stock for a total transaction value of $982,264, as disclosed in an SEC filing. This insider transaction occurred on August 13, leading to a slight dip in ICU Medical's …
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc. (NASDAQ:ICUI), sold 5,417 shares of the company's common stock for $982,264 on August 13, 2026, at $181.33 per share. This sale occurred as ICUI shares are near their 52-week high, following strong Q2 results where …
Daniel Woolson, VP and GM-Infusion Capital at ICU Medical Inc. (ICUI), sold 5,417 shares of common stock at $181.33 per share on August 13, 2026. After this transaction, Woolson directly holds 17,062 shares of ICU Medical common stock. The sale was not conducted under …
Janus Henderson Group Ltd. has reported a beneficial ownership of 2,781,621 shares of ICU Medical, Inc. common stock, which constitutes 11.1% of the class. These shares are held through various Managed Portfolios where Janus Henderson's affiliated Asset Managers exercise investment and voting discretion, though …
ICU Medical Inc's Chief Information Officer, Ben Sousa, sold 2,250 shares of the company's stock for approximately $401,220. This transaction contributes to a trend of insider selling at the company, with 9 sells versus 2 buys over the last year. The stock is currently …
ICU Medical (ICUI) reported strong Q2 CY2026 results, exceeding analyst expectations for revenue, adjusted EPS, and EBITDA, driven by robust performance in Infusion Systems and Consumables. The article highlights key analyst questions from the earnings call, focusing on the drivers of Infusion Systems growth, …
ICU Medical Inc./DE's Chief Information Officer, Ben Sousa, reported the sale of 2,250 shares of common stock on August 12, 2026, at a price of $178.3152 per share. This transaction leaves him with 3,076 shares of directly held common stock. The sale was executed …
An insider at ICU Medical, Inc. (ICUI) plans to sell 2,250 shares of common stock with an aggregate market value of $401,209.20 through Morgan Stanley Smith Barney LLC Executive Financial Services. These shares were acquired via equity compensation events, including restricted stock vesting in …
An insider at ICU Medical (ICUI) sold shares valued at $401,209, as disclosed in a recent SEC filing. This transaction occurred on August 12, 2026, adding to previous insider sales announcements for the company. ICU Medical manufactures medical products for infusion therapy, vascular access, …
Christian Voigtlander, an insider at ICU Medical Inc (ICUI), recently sold 8,929 shares for approximately $1.63 million, reducing his direct ownership to 37,377 shares. This sale contributes to a trend of more insider selling than buying at ICUI over the past year (8 sells …
Elisha W. Finney, a director at ICU Medical Inc./DE (NASDAQ:ICUI), sold 378 shares of common stock for $68,978 on August 11, 2026. This transaction occurred as the stock neared its 52-week high, having returned 68% over the past year. Despite the sale, Finney still …
ICU Medical COO Christian Voigtlander recently sold 8,929 shares of company stock for over $1.63 million, with transactions occurring on August 11, 2026, as the stock trades near its 52-week high. The company has shown strong financial performance, exceeding Q2 2026 expectations and raising …
ICU Medical (NASDAQ:ICUI) COO Christian Voigtlander sold 8,929 shares of the company's stock for over $1.63 million, reducing his stake by 19.28%. This sale occurred after ICU Medical reported strong quarterly earnings, surpassing analyst expectations for both EPS and revenue, while maintaining its fiscal …
ICU Medical Inc. (ICUI) Chief Operating Officer Christian B. Voigtlander sold 8,929 shares of common stock on August 11, 2026, at a weighted average price of $182.93 per share. This open-market transaction reduced his direct holdings to 37,377 shares. The sale amounted to approximately …
An insider at ICU Medical Inc. (ICUI) plans to sell 378 shares of common stock, valued at $68,978.08, through Morgan Stanley Smith Barney LLC. These shares were acquired on May 13, 2020, as restricted stock vesting for services rendered. The filing indicates 25,007,000 shares …
ICU Medical, Inc. (ICUI) has filed a Form 144 indicating a planned resale of 8,929 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares, valued at approximately $1,633,403.62, are related to previously exercised options and vesting equity awards, …
ICUI Q2 Deep Dive: Margin Expansion and Infusion Systems Drive Outperformance Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2026 results beating Wall Street's revenue expectations , but sales were flat year on year at $547.9 million. Its non-GAAP profit of $2.37 per share …
This article analyzes Icu Medical Inc. (ICUI) through AI models, identifying strong sentiment across all horizons and no resistance levels above the current price, suggesting upside potential. It outlines three institutional trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk …
ICU Medical (ICUI) Shares Skyrocket, What You Need To Know What Happened? Shares of medical device company ICU Medical (NASDAQ:ICUI) jumped 10.2% in the afternoon session after the company posted strong second-quarter results that surpassed Wall Street expectations and raised its full-year earnings forecast. …
ICU Medical (ICUI) has seen its analyst fair value increase from US$172.50 to US$191.50 due to positive analyst revisions and target hikes. Analysts cite improving margins, progress on free cash flow, and strong execution as reasons for their bullish outlook, with some firms raising …
ICU Medical, Inc. recently reported its latest quarterly earnings, surpassing analyst expectations. Following these positive results, analysts have updated their financial forecasts for the company, indicating a potential shift in their outlook. Investors will be keen to see how these revised expectations might impact …
Reinhart Partners LLC. has invested $46.15 million in ICU Medical, Inc., acquiring 314,768 shares during the second quarter, making them a significant institutional holder. This investment comes as ICU Medical reported strong second-quarter earnings, beating analyst expectations and raising its fiscal 2026 EPS guidance. …
Wall Street Zen has upgraded ICU Medical (NASDAQ:ICUI) to a "strong-buy" rating, reflecting generally positive analyst sentiment and recent strong financial performance. The company exceeded quarterly expectations with EPS of $2.37 and revenue of $547.9 million, and it provided optimistic fiscal 2026 EPS guidance. …
Seven analysts have raised the average 12-month price target for ICU Medical, Inc. (ICUI) stock from $176.43 to $194.14, with individual forecasts ranging from $187 to $200 per share. This new target suggests a potential upside of approximately 17% based on the August 6th …
ICU Medical, Inc. (ICUI) published its Q2 2026 earnings call presentation on August 7, 2026. The company reported an EPS of $2.37, beating estimates by $0.46, and revenue of $547.88 million, exceeding expectations by $13.94 million despite a slight year-over-year decrease. This article was …
Piper Sandler has increased its target price for ICU Medical, Inc. (ICUI.O) to $195 from $163. This update was reported by Reuters on August 7, 2026. The article itself is a brief announcement of this change.
Search by ticker symbol or company name and select a result to open its chart.